John Latham
Consultant / Adviseur bij Accelerator Services Corp
Actieve functies van John Latham
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Consultant / Adviseur | - | - |
Loopbaan van John Latham
Eerdere bekende functies van John Latham
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ALDER BIOPHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2004 | 05-04-2019 |
Oprichter | 01-01-2004 | 05-04-2019 | |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Corporate Officer/Principal | 01-01-1998 | 01-01-2004 |
Darwin Molecular Corp
Darwin Molecular Corp Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Darwin Molecular Corp is a biotechnology research and development firm. The company is based in Bothell, WA. Darwin Molecular was acquired by Celltech Group Plc on November 20, 1996 for $120 million. | Corporate Officer/Principal | 01-01-1994 | 01-01-1998 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-01-1989 | 01-01-1994 |
Opleiding van John Latham
Massachusetts Institute of Technology | Doctorate Degree |
Colorado State University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Verenigd Koninkrijk | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoraal
Health Technology | 4 |
Finance | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Lundbeck Seattle BioPharmaceuticals, Inc.
Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
Darwin Molecular Corp
Darwin Molecular Corp Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Darwin Molecular Corp is a biotechnology research and development firm. The company is based in Bothell, WA. Darwin Molecular was acquired by Celltech Group Plc on November 20, 1996 for $120 million. | Commercial Services |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
- Beurs
- Insiders
- John Latham
- Ervaring